TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07641179: A Study to Evaluate MAR002 for Acromegaly

Sponsor: Marea Therapeutics · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 72 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$4,083,600

Rescue Site Savings

+$2,689,200

Unlock Full NCT07641179 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07641179 Rescue Dossier →